Johnson & Johnson offers $5.5bn settlement in talc baby powder cancer lawsuits
Johnson & Johnson has agreed to pay $5.5 billion to settle nearly 70,000 US lawsuits alleging that its talc-based baby powder caused cancer.
Pharmaceutical giant Johnson & Johnson (J&J) announced it will pay $5.5 billion to resolve nearly 70,000 US lawsuits. The cases claim that the company's talc-based baby powder was linked to cancer development.
The settlement covers lawsuits where plaintiffs alleged that long-term use of talc powder led to cancer. J&J has faced thousands of similar claims for years, making this one of the largest proposed settlements in its history.
The company denies any wrongdoing and emphasizes that the settlement is not an admission of liability. However, to end prolonged litigation, J&J chose to reach an agreement. The total $5.5 billion will be distributed among claimants based on their individual cases.
This move could help the company reduce legal uncertainty and focus on its core business. However, some plaintiffs have expressed dissatisfaction, believing the amount is insufficient. The settlement still requires approval from a US court.
